Health
Moderna COVID-19 vaccine well-tolerated, generates immune response in older adults: Study – The Indian Express
The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants,…
By: AP | Boston |
Updated: September 30, 2020 7:40:28 pm
According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination. (AP/File)Results from the Phase 1 trial of an investigational COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune…
-
General13 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News16 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News22 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business18 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth